Literature DB >> 21804121

Update in lung cancer and oncological disorders 2010.

Balazs Halmos1, Charles A Powell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21804121      PMCID： PMC3175537          DOI： 10.1164/rccm.201103-0370UP

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  71 in total

1.  EML4-ALK fusion gene assessment using metastatic lymph node samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration.

Authors:  Yuichi Sakairi; Takahiro Nakajima; Kazuhiro Yasufuku; Dai Ikebe; Hajime Kageyama; Manabu Soda; Kengo Takeuchi; Makiko Itami; Toshihiko Iizasa; Ichiro Yoshino; Hiroyuki Mano; Hideki Kimura
Journal:  Clin Cancer Res       Date:  2010-10-05       Impact factor: 12.531

2.  Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Authors:  Eunice L Kwak; Yung-Jue Bang; D Ross Camidge; Alice T Shaw; Benjamin Solomon; Robert G Maki; Sai-Hong I Ou; Bruce J Dezube; Pasi A Jänne; Daniel B Costa; Marileila Varella-Garcia; Woo-Ho Kim; Thomas J Lynch; Panos Fidias; Hannah Stubbs; Jeffrey A Engelman; Lecia V Sequist; WeiWei Tan; Leena Gandhi; Mari Mino-Kenudson; Greg C Wei; S Martin Shreeve; Mark J Ratain; Jeffrey Settleman; James G Christensen; Daniel A Haber; Keith Wilner; Ravi Salgia; Geoffrey I Shapiro; Jeffrey W Clark; A John Iafrate
Journal:  N Engl J Med       Date:  2010-10-28       Impact factor: 91.245

3.  EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors.

Authors:  Young Lim Choi; Manabu Soda; Yoshihiro Yamashita; Toshihide Ueno; Junpei Takashima; Takahiro Nakajima; Yasushi Yatabe; Kengo Takeuchi; Toru Hamada; Hidenori Haruta; Yuichi Ishikawa; Hideki Kimura; Tetsuya Mitsudomi; Yoshiro Tanio; Hiroyuki Mano
Journal:  N Engl J Med       Date:  2010-10-28       Impact factor: 91.245

4.  Cancer risks after radiation exposure in middle age.

Authors:  Igor Shuryak; Rainer K Sachs; David J Brenner
Journal:  J Natl Cancer Inst       Date:  2010-10-25       Impact factor: 13.506

5.  Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial.

Authors:  P E Van Schil; P Baas; R Gaafar; A P Maat; M Van de Pol; B Hasan; H M Klomp; A M Abdelrahman; J Welch; J P van Meerbeeck
Journal:  Eur Respir J       Date:  2010-06-04       Impact factor: 16.671

6.  Host-derived interleukin-5 promotes adenocarcinoma-induced malignant pleural effusion.

Authors:  Georgios T Stathopoulos; Taylor P Sherrill; Sophia P Karabela; Kasia Goleniewska; Ioannis Kalomenidis; Charis Roussos; Barbara Fingleton; Fiona E Yull; R Stokes Peebles; Timothy S Blackwell
Journal:  Am J Respir Crit Care Med       Date:  2010-07-01       Impact factor: 21.405

7.  Macrophage migration inhibitory factor promotes tumor growth in the context of lung injury and repair.

Authors:  Douglas Arenberg; Tracy R Luckhardt; Shannon Carskadon; Liujian Zhao; Mohammad A Amin; Alisa E Koch
Journal:  Am J Respir Crit Care Med       Date:  2010-06-25       Impact factor: 21.405

8.  Chromosome 4q31 locus in COPD is also associated with lung cancer.

Authors:  R P Young; C F Whittington; R J Hopkins; B A Hay; M J Epton; P N Black; G D Gamble
Journal:  Eur Respir J       Date:  2010-12       Impact factor: 16.671

9.  Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial.

Authors:  Jouke T Annema; Jan P van Meerbeeck; Robert C Rintoul; Christophe Dooms; Ellen Deschepper; Olaf M Dekkers; Paul De Leyn; Jerry Braun; Nicholas R Carroll; Marleen Praet; Frederick de Ryck; Johan Vansteenkiste; Frank Vermassen; Michel I Versteegh; Maud Veseliç; Andrew G Nicholson; Klaus F Rabe; Kurt G Tournoy
Journal:  JAMA       Date:  2010-11-24       Impact factor: 56.272

10.  In-home coal and wood use and lung cancer risk: a pooled analysis of the International Lung Cancer Consortium.

Authors:  H Dean Hosgood; Paolo Boffetta; Sander Greenland; Yuan-Chin Amy Lee; John McLaughlin; Adeline Seow; Eric J Duell; Angeline S Andrew; David Zaridze; Neonila Szeszenia-Dabrowska; Peter Rudnai; Jolanta Lissowska; Eleonóra Fabiánová; Dana Mates; Vladimir Bencko; Lenka Foretova; Vladimir Janout; Hal Morgenstern; Nathaniel Rothman; Rayjean J Hung; Paul Brennan; Qing Lan
Journal:  Environ Health Perspect       Date:  2010-09-15       Impact factor: 9.031
View more
  4 in total

Review 1.  Acquisition and processing of endobronchial ultrasound-guided transbronchial needle aspiration specimens in the era of targeted lung cancer chemotherapy.

Authors:  William Bulman; Anjali Saqi; Charles A Powell
Journal:  Am J Respir Crit Care Med       Date:  2011-10-27       Impact factor: 21.405

Review 2.  Screening for lung cancer using low-dose spiral CT: 10 years later, state of the art.

Authors:  M Zompatori; M Mascalchi; F Ciccarese; N Sverzellati; U Pastorino
Journal:  Radiol Med       Date:  2012-06-28       Impact factor: 3.469

Review 3.  Pulmonary adenocarcinoma: implications of the recent advances in molecular biology, treatment and the IASLC/ATS/ERS classification.

Authors:  Swaroop Revannasiddaiah; Priyanka Thakur; Bhaskar Bhardwaj; Sridhar Papaiah Susheela; Irappa Madabhavi
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

4.  Integrating palliative care with intensive care for critically ill patients with lung cancer.

Authors:  Elizabeth B Gay; Stefanie P Weiss; Judith E Nelson
Journal:  Ann Intensive Care       Date:  2012-02-16       Impact factor: 6.925
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.